Status:
RECRUITING
Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease
Lead Sponsor:
Lithuanian University of Health Sciences
Conditions:
Chronic Obstructive Pulmonary Disease Moderate
Chronic Obstructive Pulmonary Disease Severe
Eligibility:
All Genders
40+ years
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a major cause of disability and death worldwide. People with COPD often have cardiovascular diseases (CVDs) that are associated with increased risk for ...
Eligibility Criteria
Inclusion
- Aged 40 years and older
- Smoking index of 10 pack-years and more
- Newly diagnosed chronic obstructive pulmonary disease (COPD) with forced expiratory volume in 1 second (FEV1) 30-79 percent of predicted and forced expiratory volume in 1 second to forced vital capacity ratio (FEV1/FVC) less than 70 percent of predicted.
Exclusion
- Active lung infection
- Present or previously treated lung cancer
- Alpha-1 antitrypsin deficiency
- Diagnosed interstitial lung disease
- Previously diagnosed asthma
- Diagnosed chronic hypercapnic respiratory failure
- Treatment with systemic glucocorticoids
- Unstable ischaemic heart disease
- Pregnancy
- Present cardiac arrhythmias
- Uncontrolled arterial hypertension
- Dementia and other mental states that determine patient's inability to consent
- Other medical conditions that in the opinion of the investigator disqualify the subject for inclusion
Key Trial Info
Start Date :
April 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06072690
Start Date
April 15 2021
End Date
August 31 2026
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lithuanian University of Health Sciences
Kaunas, Lithuania, 44307